Danguole Altman, an experienced health care entrepreneur, is the Founder and immediate past President and CEO of Vapogenix (www.vapogenix.com). Vapogenix is a clinical stage pharmaceutical company developing a suite of innovative, non-opioid products for preventing and treating localized pain. Ms. Altman lead Vapogenix from pre-clinical development through to a Phase 2 Proof-of-Concept trial for its lead product, a topical analgesic for use in painful wounds.
Ms. Altman was previously President and CEO of FemPartners, Inc., a private-equity backed women’s health care services firm that she co-founded and grew to be one of the nation’s largest women’s health care services firms. Prior to FemPartners, Ms. Altman held management positions at HCA and Kelsey-Seybold Clinic, as well as at McKinsey and Co., where she served as an engagement manager in the health care practice.
Ms. Altman serves on the Advisory Board of the Women Business Leaders of the U.S. Healthcare Industry Foundation, as a member of the Greater Houston Partnership’s Executive Women’s Partnership, and in 2008 was named a Woman on the Move by Texas Executive Women and the Houston Chronicle. In addition to her service as a Director of the Baltic American Freedom Foundation, she also serves on the Executive Committee of the Harvard Alumni Association Board. Ms. Altman holds an A.B in Economics magna cum laude from Harvard University and an M.B.A. from the Yale School of Management. Last year, she was named a Donaldson Fellow by the Yale School of Management for her contributions to business and society, its highest alumni honor. Ms. Altman was recently recognized as one of the 100 most honorable women of Lithuania.